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INTRODUCTION:  Perivascular  Epithelioid  Cell  tumor  (PEComa)  is  a rare  neoplasm  of mesenchymal  origin,
with the  uterus  being  the  most  common  site  of appearance,  regarding  the  female  genital  tract.
CASE  REPORT:  We  present  two cases  of PEComas  of the  uterus  in  patients  aged  57  and  42-years-old,
presented  to our  department  with  palpable  abdominal  masses  and  abnormal  vaginal  bleeding.  During
follow  up  period,  both  patients  are  free  of recurrent  disease  one  and  two  years  after  surgery,  respectively,eywords:
terine PEComa
bdominal mass
esenchymal neoplasms
ase report
MB-45
without  receiving  any  adjuvant  treatment.
CONCLUSIONS:  PEComa  of the  female  gynecological  tract  is  a  rare  entity  presenting  with  variable  symp-
toms  and  different  prognosis  for each  individual  case.  The  diagnosis  is based  on histopathology  and
immunohistochemistry  reports  and  the  optimal  treatment  is the  surgical  resection  of the tumor.
© 2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Perivascular epithelioid cell tumor is a rare mesenchymal neo-
lasm. It originates from the perivascular epithelioid cell (PEC)
ine and was ﬁrst described in 1943 as an abnormal myoblast
1]. Several years later and through morphological and immuno-
istochemical studies, these tumors showed an unusual cell
ype with a perivascular distribution. Moreover, these cells are
haracterized immunoreactive for melanocytic markers, with an
pithelioid appearance and a clearacidophilic cytoplasm, thus the
erm “perivascular epithelioid” was introduced [2]. Progressively,
his family of tumors came to include angiomyolipoma, clear
ell sugar tumors, lymphangioleiomyomatosis, clear cell myome-
anocytic tumor of the falciform ligament and other clear cell
umors [3]. According to World Health Oraganization (WHO),
EComas are now deﬁned as mesenchymal tumors composed of
istologically and immunohistochemically distinctive perivascular
pithelioid cells [4].
PEComas of the female gynecological tract account for nearly
5% of all the PEComa cases worldwide [5]. In most of the PEComa
ases, the original site of appearance of the tumor was  the uterine
orpus, while there are a few reports in the literature where the
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reativecommons.org/licenses/by-nc-nd/4.0/).cervix is involved [6–8]. Most patients are in their 40 s and the lack
of non-speciﬁc clinical features makes the tumor hard to diagnose.
In most of the cases, PEComa presents with abnormal vaginal or
peritoneal bleeding, abdominal pain and uterine symptoms, such as
rupture of the uterus and hemoperitoneum, while the radiological
appearance is also a diagnostic challenge [7–9].
Uterine PEComas are classiﬁed as i.benign neoplasms, ii. tumors
of uncertain malignant potential and iii. malignancies. Six high-
risk criteria have been proposed for the classiﬁcation of PEComas:
tumor size ≥ 5 cm,  inﬁltrative growth pattern, high nuclear grade
cellularity, mitotic rate > 1/50 high power ﬁleds (HPF), necrosis
and vascular invasion [10]. Tumors are classiﬁed as benign when
they present with no features associated with malignancy. The
term “uncertain malignant potential” refers to neoplasms that are
characterized by a single histological feature, including nuclear
pleomorphism or multinucleated giant cells or a size ≥ 5 cm.
Malignant tumors are the ones that show 2 or more of the afore-
mentioned criteria [11].
2. Case report 1
A 57-year-old Caucasian woman presented to our clinic with a
palpable abdominal mass and symptoms of obstructive uropathy.
Her past medical history included a total abdominal hysterectomy
15 years ago due to uterine ﬁbromas and abnormal menstrual
bleeding. Histopathology also reported a simple endometrial
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. Immunohistochemical stain HMB-45 positive.Fig. 1. Spindled and epithelioid cells with perivascular localisation.
yperplasia without atypia. Four years later she underwent another
urgery due to an abdominal mass located in the pouch of Dou-
las that was strictly attached to the sigmoid colon. The mass
as removed and a radical omentectomy and bilateral salpingo-
ophorectomy was conducted. Histopathology report stated that
he mass was a ﬁbroma with no malignant characteristics.
Physical examination during her last visit showed a large
bdominal mass. CT scans revealed two more of reducable size,
ocated at the parametria, that were adjacent to both ureters. The
asses were surgically removed and small parts of both ureters
ad to be excised while ureteral catheters (pig-tails) were placed
n order to resume the synechiae of the urinary tract.
Macroscopic analysis showed a pelvic mass sized 13 × 13 × 7 cm
nd two smaller ones at the right and the left parametrium, sized
 cm and 8 cm,  respectively. Histopathology report showed that all
he tumors removed were of mesenchymal origin with epithelioid
nd necrotic characteristics (Fig. 1). The tumor cells had a mitotic
ate of 10/50 HPF and immunohistochemistry report came back
ositive for HMB-45, SMA, h-Caldesmon and p53 while negative
or p16 and S100. The report concluded that the morphological and
mmunophenotypical characteristics of the tumor were compliant
ith a Perivascular Epithelioid Cell tumor.
. Case report 2
A 42-year-old Caucasian woman presented to our clinic with
elvic tenderness upon physical examination and adnormal men-
trual bleeding. CT scans showed a mass at the uterine wall sized
 cm with no other pathology. She had a free medical history with
o prior surgeries. The patient underwent a dilation and curettage
rior to abdominal myomectomy. Histopathology report showed
 neoplasm of mesenchymal origin, with immunophenotypical
haracteristics compliant with Perivascular Epithelioid Cell tumor.
he cells showed a mitotic rate < 1/50 HPF. Immunohistochemistry
eport was positive for the melanocytic marker HMB-45 (Fig. 2) and
he smooth muscle markers SMA  and desmin, while h-caldesmon
arker was negative.
. Discussion
In this study, we report two cases of uterine PEComas in patients
ith variable symptoms and different medical history. In both
ases, an abdominal mass was found by CT scan.
In the ﬁrst case, the patient had recurrent surgeries due to
bdominal masses and her latest symptoms included obstructive
ropathy. Uterine PEComa was diagnosed after the third surgery,
ith the two prior histopathology reports stating uterine ﬁbromas.
his constitutes a case of primary uterine PEComa in the basis of
 history of a ﬁbromatus uterus. The recurrence of the abdom-inal masses could raise the hypothesis of a correlation between
benign ﬁbromas and tumors of mesenchymal origin, such as PECo-
mas. The tumor was characterized by epithelioid cell morphology,
with cells presenting variability in size and shape. Immunohisto-
chemistry revealed expression of the melanocytic marker HMB-45
and the smooth muscle marker h-Caldesmon. The morphologic fea-
tures and the immunohistochemical staining pattern supported a
diagnosis of PEComa.
In the second case, the patient had a clear medical history
with no prior surgeries or admissions to a hospital. She presented
with abdominal pain and abnormal menstrual bleeding. After
the patient’s desire to retain her uterus, an abdominal myomec-
tomy was  performed. Histopathology report stated that the tumor
cells had exhibited no atypia and no prominent nuclei. However,
immunohistochemistry report showed that the tumor expressed
the melanocytic marker HMB-45 and the smooth muscle markers
SMA  and desmin, suggesting a case of uterine PEComa.
Bonetti et al. introduced ﬁrst the term Perivascular Epithelioid
Cell tumor in 1992 [2]. Ten years later, the World Health Orga-
nization deﬁned PEComas as mesenchymal tumors composed of
perivascular epithelioid cells that express both melanocytic and
smooth muscle markers [4]. The origin of PEComas remains yet
unknown but studies suggest that they arise from neural stem cells
that present with the ability to differentiate into both myoid and
melanocytic cells [12,13]. Apart from our two, there have been
78 reported cases of uterine PEComas in the literature, the most
common site being the female genital tract [14].
PEComas express both melanocytic marker HMB-45 and smooth
muscle marker SMA  [12]. In our study, these melanocytic and
smooth muscle markers were expressed in both cases. In patients
with mesenchymal tumors of the uterus, apart from leiomyosar-
comas and endometrial stromal sarcomas, PEComas should be
considered in the differential diagnosis, despite the fact that dis-
tinguishing these mesenchymal neoplasms could be very difﬁcult.
Even though PEComas are usually positive for melanocytic mark-
ers, there have been reports in the literature of leiomyosarcomas
and ESS tumors expressing HMB-45 [15,16].
Regarding PEComas, it seems that the optimal treatment is sur-
gical resection of the tumor. For non-aggressive PEComas, surgery
is the treatment of choice, while it has been demonstrated that,
in cases of high-risk patients with underlying morbidity, preop-
erative or neoadjuvant treatment seems beneﬁcial [17]. In both
our cases, patients are free of recurrent disease one and two  years
after surgery, respectively, without receiving any adjuvant treat-
ment. However, the fact that PEComas are extremely rare, makes
it hard to conduct randomized controlled trials, in order to assess
the outcome of each therapeutic approach.
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. Conclusions
PEComas of the female gynecological tract are a rare entity
hat presents with variable symptoms and different prognosis for
ach individual case. The diagnosis is based on histopathology and
mmunohistochemistry reports and the optimal treatment should
e individualized for each patient. However, it seems that surgical
esection of the disease is the ideal approach and a close follow-
p is obligatory in order to assess the need of adjuvant therapy.
atients should be thoroughly examined with a detailed history,
hile molecular genetic studies seem to be the future in under-
tanding the nature of these tumors.
eferences
[1] K. Apitz, Die geschwulste und Gewebsmissbildungen Nierenrinde: Il
Midteilung Die mesenchymalen Neubildungen, Virchows Arch. 311 (1943)
306–327.
[2] F. Bonetti, et al., PEC and sugar, Am.  J. Surg. Pathol. 16 (1992) 307–308.
[3] A. Musella, et al., Perivascular epithelioid cell neoplasm (PEComa) of the
uterus: a systematic review, Int. J. Surg. 19 (2015) 1–5.
[4] A.I. Folpe, Neoplasms with perivascular epithelioid cell differentiation(PEComas), in: C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.), World Health
Classiﬁcation of Tumorspathology and Genetics of Tumors of Soft Tissue and
Bone, IARC Press, Lyon, 2002, p. 221.
[5] A. Agaimy, P.H. Wunsch, Perivasular epithelioid cell sarcoma (malignant
PEComa) of the ilium, Pathol. Res. Pract. 202 (2006) 37–41.
[
[
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
 Surgery Case Reports 28 (2016) 85–87 87
[6] N.S. Azad, et al., Uterine perivascular epithelioid cell tumour presenting as a
cervical mass, J. Pak. Med. Assoc. 56 (2) (2006) 83–84.
[7] S.R. Prasad, et al., Neoplasms of the perivascular epithelioid cell involving the
abdomen and the pelvis: cross-sectional imaging ﬁndings, J. Comput. Assist.
Tomogr. 31 (5) (2007) 688–696.
[8] C. Phongnarisorn, et al., Laparoscopic radical excision of primary round
ligament perivascular epithelioid cell tumor mimicking leiomyoma, J. Minim.
Invasive Gynecol. 16 (5) (2009) 626–629.
[9] N. Pattamapaspong, et al., Malignant perivascular epithelioid cell tumour of
the round ligament mimics leiomyoma, J. Minim. Invasive Gynecol. 16 (5)
(2009) pe239–e242.
10] A.I. Folpe, et al., Perivascular epithelioid cell neoplasms of soft tissue and
gynecologic origin: a clinicopathologic study of 26 cases and review of the
literature, Am.  J. Surg. Pathol. 29 (12) (2005) 1558–1575.
11] A.I. Folpe, D.J. Kwiatkowski, Perivascular epithelioid cell neoplasms:
pathology and pathogenesis, Hum. Pathol. 41 (1) (2010) 1–15.
12] N. Conlon, R.A. Soslow, R. Murali, Perivascular epithelioid tumours (PEComas)
of  the gynaecological tract, J. Clin. Pathol. 68 (6) (2015) 418–426.
13] A. Fernandez-Flores, Evidence of neural crest origin of PEComas, Rom. J.
Morphol. Embryol. 52 (2011) 7–13.
14] M.  Fitzpatrick, et al., Perivascular epithelioid cell tumor of the uterus with
ovarian involvement: a case report and review of the literature, Am.  J. Case
Rep. 17 (2016) 309–314.
15] J. Albores-Saavedra, et al., Endometrial stromal sarcomas: immunoproﬁle
with emphasis on HMB-45 reactivity, Am.  J. Clin. Pathol. 141 (6) (2014)
850–855.
16] K.W. Simpson, J. Albores-Saavedra, HMB-45 reactivity in conventional uterine
leiomyosarcomas, Am. J. Surg. Pathol. 31 (2007) 95–98.
17] N. Zekry, et al., Perivascular epithelioid cell neoplasms: a systematic review of
prognostic factors, J. Minim. Invasive Gynecol. 16 (5) (2009) 527–532.uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
